Message from Amanda Scott, NanoApps Medical CEO:
If you are reading this you probably searched for the Chakravarthy Lab website on google and noticed all links to the site go nowhere.
So you tried this link – since it appears in searches immediately under links to the non-existent website for Chakravarthy Lab.
Frank Boehm and NanoApps Medical Inc and Amanda Scott have NO relationship anymore with Dr Krishnan Chakravarthy and his Chakravarthy Lab San Diego.
We built his website, paid for the rights to use images and even made the site GDPR compliant. He didn’t pay his bill despite requesting an Invoice. He has since ignored all efforts to contact him and settle his account. Therefore, we regrettably repossessed his site and will refer this matter to debt collectors in San Diego.
Therefore, the following content – which was posted on July 2 2018 – is no longer valid.
There will be a further statement on this in due course.
You can reach me directly here at email@example.com should you require any explanation or clarification in the meantime.
Amanda Scott – CEO NanoApps Medical Inc
Published on July 2 2018:
The primary goals of the Chakravarthy Lab are to investigate the pathophysiology and mechanisms of chronic pain in the context of complex regional pain syndrome (CRPS), diabetic neuropathy, persistent postsurgical pain and neuropathic pain. Further, our lab focuses on how volatile anesthetics and various pain modulators affect host immunity to viral and bacterial infections.
Frank Boehm has been involved with nanotechnology and especially nanomedicine since 1996.
He initiated and serves as CEO of NanoApps Medical Incorporated. The aim of this company is to investigate and develop advanced, innovative, and cost effective nanomedical diagnostic and therapeutic devices and systems for the benefit of individuals in both the developing and developed worlds.
Frank is the author of Nanomedical Device and Systems Design: Challenges, Possibilities, Visions, which was published by CRC Press, and is currently generating two new books. He will serve as Industry Liaison for the Chakravarthay Lab, and work to facilitate and expedite the translation of advanced nanomedical technologies to commercialization on a global scale.
Visit the Chakravarthy Lab site.
EPFL scientists have developed a chemical method for targeting the effects of cancer-fighting immunotherapy drugs only to the tumor tissue, making the drugs less toxic to the rest of [...]
Modern Approaches to Augmentation of Brain Function Available from Springer Press This book covers recent advances in neural technology that provide for enhancements for brain function. It addresses a [...]
Although the currently available COVID-19 vaccines are highly effective, limited manufacturing capacity and the need for cold-chain storage hinder their global distribution. A recent study tested the efficacy of [...]
Fully vaccinated people were 11 times less likely to die of COVID and 10 times less likely to be hospitalized compared to the unvaccinated since highly contagious Delta became [...]
The highly-infectious Delta coronavirus variant has spread to at least 174 countries worldwide, from the US to Australia, causing a surge in COVID-19 cases. The variant has mutations that help it partially escape [...]
Fragile mRNA molecules used in COVID-19 vaccines can’t get into cells on their own. They owe their success to lipid nanoparticles that took decades to refine. Messenger RNA (mRNA) [...]
The COVID-19 pandemic has revealed critical knowledge gaps and assumptions concerning how respiratory viruses spread between hosts. Traditionally thought to be spread mainly through large respiratory droplets produced by the coughs [...]
SARS-CoV-2 is just one of nonillions of viruses on our planet, and scientists are rapidly identifying legions of new species. Mya Breitbart has hunted novel viruses in African termite [...]
As a team of South African researchers we have identified a new lineage of SARS-CoV-2, the virus causing COVID-19. A lineage represents a genetically distinct virus population with a common ancestor. This virus may [...]
Citing the possibility of another serious pandemic, the Biden administration on Friday laid out a plan to transform the nation’s ability to respond to major biological threats. As staggering [...]
How doctors can predict which patients are more likely to die of COVID Several studies have come out about the COVID prognosis. As a result, we now have [...]
Though Delta continues to be the dominant COVID-19 strain, the World Health Organization (WHO) now says there's a new variant to keep your eye on. The B.1.621 variant, also [...]
Being fully vaccinated against Covid-19 not only cuts the risk of catching it, but also of an infection turning into long Covid, research led by King's College London suggests. [...]
Moderna Inc.’s Covid vaccine generated more than double the antibodies of a similar shot made by Pfizer Inc. and BioNTech SE in research directly comparing immune responses to the [...]
A coronavirus variant first detected in South Africa 'could be more infectious' than other mutations and have the potential to 'evade vaccines', scientists have said. The C.1.2 strain, which is linked to 'increased [...]
The mutation rate of SARSCoV2 is at least 50% higher than previously thought. The virus mutates about once a week—significantly higher than the rate estimated previously. UK findings suggest [...]
An artificial neural network (AI) designed by an international team involving UCL can translate raw data from brain activity, paving the way for new discoveries and a closer integration [...]
Protection against the coronavirus is waning among those who have received both shots of the AstraZeneca and Pfizer vaccines, a new U.K. study has found. An analysis from the [...]
In a significant step forward in understanding the crucial role tissue-resident memory T (TRM) cells play in the immune system, researchers have for the first time described how the [...]
We’re approaching the year-and-a-half mark of the globe’s collective experience with the SARS-CoV-2 virus and the Covid-19 pandemic it has triggered. At this point, it’s fair to assume people [...]
Pfizer CEO Albert Bourla said on Tuesday that he believes it is 'likely' that a strain of COVID-19 could emerge that is resistant to vaccines. However, the pharmaceuticals boss claimed that the company [...]
The US Food and Drug Administration on Monday granted full approval to the Pfizer/BioNTech Covid-19 vaccine for people age 16 and older. This is the first coronavirus vaccine approved [...]